Byron Hyde
Dr. Bryon Marshall Hyde is a family practice physician in Ottawa, Canada, who has dedicated his practice solely to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) since 1984, after several of his colleagues developed the illness.[1] In 1988, he founded the Nightingale Research Foundation, which is committed to exploring and understanding myalgic encephalomyelitis (ME), chronic fatigue syndrome (CFS), and fibromyalgia-type illnesses.[2]
Dr. Hyde has traveled extensively to study ME and examine patients, spending time at: the Centers for Disease Control and Prevention (CDC), in Atlanta, US; Beth Israel Deaconess Medical Center, Boston, US; the UK; Australia; New Zealand; and Akureyri, Iceland.[1][2]
In 1991, Dr. Hyde organized the first World Symposium on M.E. at Cambridge University in collaboration with Dr. John Richardson and the Newcastle Research Group in the UK.[2]
Education[edit | edit source]
- 1961, University of Toronto in Food Chemistry and Nutrition[3]
- 1966, MD - University of Ottawa’s Faculty of Medicine[2][3]
- Internship at Hôtel-Dieu de Montréal in Neuro and Vascular Surgery[3]
- Residency at the St. Justine Paediatric Hospital and the Ottawa Civic Hospital[2][3]
Notable studies[edit | edit source]
- 2003, Clinical Improvement in Chronic Fatigue Syndrome Is Associated with Enhanced Natural Killer Cell-Mediated Cytotoxicity: The Results of a Pilot Study with Isoprinosine®[4] (Abstract)
- 2007, Thyroid malignancy association with cortical & subcortical brain SPECT changes in patients presenting with a myalgic encephalomyelitis / Chronic Fatigue Syndrome[5] (Abstract)
- 2011, TCP (tricresyl phosphate): pilot, aircrew and passenger safety and secondary myalgic encephalomyelitis[6] (Full text)
Clinic location[edit | edit source]
- Nightingale Research Foundation
- 121 Iona Street, Ottawa Ontario K1Y 3M1, Canada
- info@nightingale.ca
Talks & interviews[edit | edit source]
- 2006, A new and simple definition of Myalgic Encephalomyelitis and a new simple definition of Chronic Fatigue Syndrome & A Brief History of Myalgic Encephalomyelitis and an Irreverent History of Chronic Fatigue Syndrome (London Conference of May 12)
- 2006, Speaker at the 1st Invest in ME International ME Conference on The epidemiology, definitions and techniques of investigation of the ME and CFS patient and the resulting pathological findings[7] DVD available
- 2007, Speaker at the 2nd Invest in ME International ME Conference on ME and Insurance companies[8] DVD available
- 2012, How I Help CFS/ME Patients in Canada - Byron Hyde, MD (Vimeo)
- 2015, Prof. Kenny de Meirleir and Dr. Byron Hyde on ME/CFS (Daily Motion)
- 2016 ME/cvs Vereniging Wetenschap voor Patienten / Science for Patients on YouTube (English with Dutch subtitles)
- 82. Introduction / Introductie - Dr. Byron Hyde, MD
- 83. Symptoms of ME / ME-symptomen -Dr. Byron Hyde, MD
- 84. CFS / CVS - Dr. Byron Hyde, MD
- 85. ME, viruses and bacteria / ME, virussen en bacteriën - Dr. Byron Hyde, MD
- 86. ME and the role of enteroviruses / ME en de rol van enterovirussen - Dr. Byron Hyde, MD
- 3-5 May 2018, ME/CFS Canadian Collaborative Team Conference - Speech titles: Brain Imaging and How to Examine a Prospective ME/CFS Patient and A Short History of ME and CFS[1]
Books and book chapters[edit | edit source]
- 1992, The Clinical and Scientific Basis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (Free PDF download)
- 2004, Chapter 3: The Complexities of Diagnosis in Handbook of Chronic Fatigue Syndrome[9] (Full text)
- 2009 and 2011, Missed Diagnoses: Myalgic Encephalomyelitis & Chronic Fatigue Syndrome
- 2009, Chapter: Diagnosis of Fatigue and Pain Syndromes: Psychiatric Text Book. John Wiley & Sons. Government and General Medical Counsel of the UK
- 2015, Association of M.E. to Polio, Polio Epidemics and Enteroviruses (60 Page Booklet), Netherlands M.E. Association (ME/cvs Vereniging), Amsterdam
- 2016, The Nightingale Research Foundation Definition for Myalgic Encephalomyelitis (M.E.)
Online presence[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ 1.0 1.1 1.2 "ME/CFS Canadian Collaborative Team Conference program" (PDF). Retrieved March 6, 2019. Cite has empty unknown parameter:
|dead-url=
(help) - ↑ 2.0 2.1 2.2 2.3 2.4 "Our Founder | Nightingale Research Foundation". nightingale.ca. Retrieved March 23, 2019. Cite has empty unknown parameter:
|dead-url=
(help) - ↑ 3.0 3.1 3.2 3.3 "CURRICULUM VITAE" (PDF). Retrieved March 23, 2019. Cite has empty unknown parameter:
|dead-url=
(help) - ↑ Diaz-Mitoma, Francisco; Turgonyi, Eva; Kumar, Ashok; Lim, Wilfred; Larocque, Louise; Hyde, Byron M. (January 2003). "Clinical Improvement in Chronic Fatigue Syndrome Is Associated with Enhanced Natural Killer Cell-Mediated Cytotoxicity: The Results of a Pilot Study with Isoprinosine®". Journal of Chronic Fatigue Syndrome. 11 (2): 71–95. doi:10.1300/J092v11n02_06. ISSN 1057-3321.
- ↑ Hyde, Byron; Leveille, Jean; Vaudrey, Sheila; Green, Tracy (2007). "Thyroid malignancy association with cortical & subcortical brain SPECT changes in patients presenting with a myalgic encephalomyelitis/Chronic Fatigue Syndrome". ALASBIMN Journal. 38 (42): 18.
- ↑ Hyde, Byron M. (2011). "TCP (tricresyl phosphate): pilot, aircrew and passenger safety and secondary myalgic encephalomyelitis" (PDF). Journal of Biological Physics and Chemistry. 11: 172–179.
- ↑ http://www.investinme.eu/IIMEC1.shtml#agenda
- ↑ http://www.investinme.eu/IIMEC2.shtml#agenda
- ↑ Handbook of chronic fatigue syndrome. Jason, Leonard, Fennell, Patricia, Taylor, Renée R. Hoboken, N.J.: Wiley. 2003. ISBN 047141512X. OCLC 50693363.CS1 maint: others (link)